Sturm Ruger & Co Inc: Form 10-Q for the period ended Sep 28, 2024
Filed with the SEC on Oct 30, 2024 and accepted by EDGAR at Oct 30, 2024, 17:02 ET.
Management's discussion and analysis
As filed, 23,201 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Company Overview
Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 5% and 7% of total sales for the nine month periods ended September 28, 2024 and September 30, 2023, respectively. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.
The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Less than 1% of sales are from the castings segment.
Orders for many models of firearms from the independent distributors tend to be stronger in the first quarter of the year and weaker in the third quarter of the year. This is due in part to the timing of the distributor show season, which occurs during the first quarter.
Results of Operations
Demand
The estimated unit sell-through of the Company’s products from the independent distributors to retailers increased 4% in the first nine months of 2024 compared to the prior year period. For the same period, National Instant Criminal Background Check System (“NICS”) background checks (as adjusted by the National Shooting Sports Foundation (“NSSF”)) decreased 3%. Estimated sell-through from the independent distributors to retailers and total adjusted NICS background checks for the trailing seven quarters follow:
| 2024 Q3 | Q2 | Q1 | 2023 Q4 | Q3 | Q2 | Q1 | |
|---|---|---|---|---|---|---|---|
| Estimated Units Sold from Distributors to Retailers (1) | 336,300 | 327,800 | 396,700 | 384,700 | 307,400 | 323,000 | 391,500 |
| Total adjusted NICS Background Checks (thousands) (2) | 3,432 | 3,364 | 3,983 | 4,742 | 3,284 | 3,654 | 4,168 |
(1) The estimates for each period were calculated by taking the beginning inventory at the distributors, plus shipments from the Company to distributors during the period, less the ending inventory at distributors. These estimates are only a proxy for actual market demand as they:
- Rely on data provided by independent distributors that are not verified by the Company,
- Do not consider potential timing issues within the distribution channel, including goods-in-transit, and
- Do not consider fluctuations in inventory at retail.
(2) NICS background checks are performed when the ownership of most firearms, either new or used, is transferred by a Federal Firearms Licensee. NICS background checks are also performed for permit applications, permit renewals, and other administrative reasons.
The adjusted NICS data presented above was derived by the NSSF by subtracting out NICS checks that are not directly related to the sale of a firearm, including checks used for concealed carry (“CCW”) permit application checks, as well as checks on active CCW permit databases. The adjusted NICS checks represent less than half of the total NICS checks.
Adjusted NICS data can be impacted by changes in state laws and regulations and any directives and interpretations issued by governmental agencies.
Orders Received and Ending Backlog
The Company uses the estimated unit sell-through of its products from the independent distributors to retailers, along with inventory levels at the independent distributors and at the Company, as the key metrics for planning production levels. The Company generally does not use the orders received or ending backlog for planning production levels.
The units ordered, value of orders received, average sales price of units ordered, and ending backlog for the trailing seven quarters are as follows (dollars in millions, except average sales price):
(All amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns.)
| 2024 Q3 | Q2 | Q1 | 2023 Q4 | Q3 | Q2 | Q1 | |
|---|---|---|---|---|---|---|---|
| Units Ordered | 316,900 | 250,500 | 472,600 | 316,600 | 176,300 | 258,100 | 408,000 |
| Orders Received | $109.4 | $99.5 | $198.2 | $116.7 | $58.8 | $102.1 | $156.2 |
| Average Sales Price of Units Ordered | $345 | $397 | $419 | $369 | $334 | $396 | $383 |
| Ending Backlog | $268.7 | $272.2 | $296.2 | $229.0 | $234.8 | $293.7 | $327.3 |
| Average Sales Price of Ending Unit Backlog | $572 | $567 | $523 | $522 | $510 | $496 | $488 |
Production
The Company reviews the estimated sell-through from the independent distributors to retailers, as well as inventory levels at the independent distributors and at the Company to plan production levels. The Company’s overall production in the third quarter of 2024 decreased 11% from the second quarter of 2024.
Summary Unit Data
Firearms unit data for the trailing seven quarters are as follows (dollar amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns):
| 2024 Q3 | Q2 | Q1 | 2023 Q4 | Q3 | Q2 | Q1 | |
|---|---|---|---|---|---|---|---|
| Units Ordered | 316,900 | 250,500 | 472,600 | 316,600 | 176,300 | 258,100 | 408,000 |
| Units Produced | 330,300 | 370,400 | 314,500 | 305,200 | 324,500 | 387,400 | 381,000 |
| Units Shipped | 327,400 | 336,300 | 345,400 | 337,800 | 308,400 | 336,400 | 384,900 |
| Average Sales Price of Units Shipped | $371 | $386 | $394 | $383 | $390 | $422 | $387 |
| Ending Unit Backlog | 469,700 | 480,200 | 566,000 | 438,800 | 460,000 | 592,100 | 670,400 |
Inventories
During the third quarter of 2024, the Company’s finished goods inventory increased by 2,900 units and distributor inventories of the Company’s products decreased by 8,900 units.
Inventory unit data for the trailing seven quarters follows:
| 2024 Q3 | Q2 | Q1 | 2023 Q4 | Q3 | Q2 | Q1 | |
|---|---|---|---|---|---|---|---|
| Company Inventory | 149,600 | 146,700 | 112,600 | 143,500 | 176,100 | 160,000 | 108,900 |
| Distributor Inventory (1) | 207,600 | 216,500 | 208,000 | 259,300 | 306,200 | 305,200 | 291,800 |
| Total Inventory (2) | 357,200 | 363,200 | 320,600 | 402,800 | 482,300 | 465,200 | 400,700 |
(1) Distributor ending inventory is provided by the Company’s independent distributors. These numbers do not include goods-in-transit inventory that has been shipped from the Company but not yet received by the distributors.
(2) This total does not include inventory at retailers. The Company does not have access to data on retailer inventories of the Company’s products.
Net Sales, Cost of Products Sold, and Gross Profit
Net sales, cost of products sold, and gross profit data for the three months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Net firearms sales | $121.5 | $120.4 | $1.1 | 1.0% |
| Net castings sales | 0.8 | 0.5 | 0.3 | 47.6% |
| Total net sales | 122.3 | 120.9 | 1.4 | 1.2% |
| Cost of products sold | 99.6 | 96.2 | 3.4 | 3.6% |
| Gross profit | $22.7 | $24.7 | $(2.0) | (8.3%) |
| Gross margin | 18.5% | 20.5% | (2.0%) | (9.8%) |
The increase in total consolidated net sales and net firearms sales for the three months ended September 28, 2024 is attributable to strong demand for certain of the Commpany’s firearms. Sales of new products, including the Security-380 pistol, Super Wrangler revolver, Marlin lever-action rifles, LC Carbine, Small-Frame Autoloading Rifle, and American Centerfire Rifle Generation II represented $35.5 million or 31.0% of firearm sales in the three months ended September 28, 2024. New product sales include only major new products that were introduced in the past two years.
The decreased gross profit for the three months ended September 28, 2024 is attributable to unfavorable deleveraging of fixed costs resulting from decreased production and a product mix shift toward products with relatively lower margins that remain in relatively stronger demand.
The decrease in gross margin for the three months ended September 28, 2024 is attributable to the aforementioned factors, partially offset by increased pricing.
Net sales, cost of products sold, and gross profit data for the nine months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Net firearms sales | $387.4 | $411.1 | $(23.7) | (5.8%) |
| Net castings sales | 2.5 | 2.1 | 0.4 | 23.7% |
| Total net sales | 389.9 | 413.2 | (23.3) | (5.6%) |
| Cost of products sold | 308.7 | 311.8 | (3.1) | (1.0%) |
| Gross profit | $81.2 | $101.4 | $(20.2) | (19.9%) |
| Gross margin | 20.8% | 24.5% | (3.7%) | (15.1%) |
24
The decrease in total consolidated net sales and net firearms sales for the nine months ended September 28, 2024 is attributable to decreased consumer demand for firearms. Sales of new products, including the Security-380 pistol, Super Wrangler revolver, Marlin lever-action rifles, LC Carbine, Small-Frame Autoloading Rifle, and American Centerfire Rifle Generation II, represented $113.3 million or 31.2% of firearm sales in the first nine months of 2024. New product sales include only major new products that were introduced in the past two years.
The decreased gross profit for the nine months ended September 28, 2024 is attributable to unfavorable deleveraging of fixed costs resulting from decreased production, a product mix shift toward products with relatively lower margins that remain in relatively stronger demand, and the decrease in sales.
The decrease in gross margin for the nine months ended September 28, 2024 is attributable to the aforementioned factors, partially offset by increased pricing.
Selling and General and Administrative Expenses
Selling and general and administrative expenses data for the three months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Selling expenses | $9.0 | $8.7 | $0.3 | 3.8% |
| General and administrative expenses | 9.9 | 9.7 | 0.2 | 2.0% |
| Total operating expenses | $18.9 | $18.4 | $0.5 | 2.9% |
The increase in selling expenses for the three months ended September 28, 2024 was attributable to increased spending on advertising, partially offset by modest reductions in several selling and marketing initiatives.
The increase in general and administrative expenses for the three months ended September 28, 2024 was primarily attributable to increased professional service costs.
Selling and general and administrative expenses data for the nine months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Selling expenses | $28.2 | $27.7 | $0.5 | 1.8% |
| General and administrative expenses | 32.8 | 31.9 | 0.9 | 2.8% |
| Total operating expenses | $61.0 | $59.6 | $1.4 | 2.3% |
25
The increase in selling expenses for the nine months ended September 28, 2024 was attributable increased spending on advertising, partially offset by modest reductions in several selling and marketing initiatives.
The increase in general and administrative expenses for the nine months ended September 28, 2024 was primarily attributable to accrued severances of $1.5 million taken in the first quarter of 2024 related to a reduction in force involving approximately 80 employees, partially offset by decreased incentive compensation expenses. The aforementioned accrued severances are expected to be settled in cash and consist of one-time termination charges arising from severance obligations and other customary employee benefit payments in connection with a reduction in force.
The reduction in force is expected to result in approximately $9 million of annualized cash savings. This action is part of the Company’s initiatives to reallocate its resources and cost structure into prioritized areas that will drive long-term growth and improve margins.
Other Income
Other income data for the three months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Other income | $1.5 | $1.8 | $(0.3) | (13.6%) |
The decrease in other income for the three months ended September 28, 2024 was attributable to decreased interest income.
Other income data for the nine months ended (dollars in millions):
| September 28, 2024 | September 30, 2023 | Change | % Change | |
|---|---|---|---|---|
| Other income | $4.5 | $5.1 | $(0.6) | (10.5%) |
The decrease in other income for the nine months ended September 28, 2024 was the result of decreases in interest income and miscellaneous income.
Income Taxes and Net Income
The Company's 2024 and 2023 effective tax rates differ from the statutory federal tax rate due principally to research and development tax credits, state income taxes and the nondeductibility of certain executive compensation. The Company’s effective income tax rate was 10.0% and 18.9% for the three and nine months ended September 28, 2024, respectively. The Company’s effective income tax rate was 8.1% and 18.9% for the three and nine months ended September 30, 2023, respectively.
As a result of the foregoing factors, consolidated net income was $4.7 million for the three months ended September 28, 2024, a decrease of 36.2% from $7.4 million in the comparable prior year period.
Consolidated net income was $20.1 million for the nine months ended September 28, 2024, a decrease of 47.1% from $38.0 million in the comparable prior year period.
Non-GAAP Financial Measures
In an effort to provide investors with additional information regarding its financial results, the Company refers to various United States generally accepted accounting principles (“GAAP”) financial measures and two non-GAAP financial measures, EBITDA and EBITDA margin, which management believes provides useful information to investors. These non-GAAP financial measures may not be comparable to similarly titled financial measures being disclosed by other companies. In addition, the Company believes that the non-GAAP financial measures should be considered in addition to, and not in lieu of, GAAP financial measures. The Company believes that EBITDA and EBITDA margin are useful to understanding its operating results and the ongoing performance of its underlying business, as EBITDA provides information on the Company’s ability to meet its capital expenditure and working capital requirements, and is also an indicator of profitability. The Company believes that this reporting provides better transparency and comparability to its operating results. The Company uses both GAAP and non-GAAP financial measures to evaluate the Company’s financial performance.
EBITDA is defined as earnings before interest, taxes, and depreciation and amortization. The Company calculates this by adding the amount of interest expense, income tax expense, and depreciation and amortization expenses that have been deducted from net income back into net income, and subtracting the amount of interest income that was included in net income from net income to arrive at EBITDA. The Company calculates EBITDA margin by dividing EBITDA by total net sales.
EBITDA was $9.9 million for the three months ended September 28, 2024, a decrease of 25.2% from $13.3 million in the comparable prior year period.
For the nine months ended September 28, 2024 EBITDA was $37.9 million, a decrease of 39.2% from $62.4 million in the comparable prior year period.
Non-GAAP Reconciliation – EBITDA
EBITDA
(Unaudited, dollars in thousands)
| Three Months Ended September 28, 2024 | September 30, 2023 | Nine Months Ended September 28, 2024 | September 30, 2023 | |
|---|---|---|---|---|
| Net income | $4,738 | $7,431 | $20,086 | $37,966 |
| Income tax expense | 527 | 658 | 4,681 | 8,848 |
| Depreciation and amortization expense | 5,804 | 6,530 | 16,941 | 19,576 |
| Interest income | (1,155) | (1,454) | (3,839) | (4,147) |
| Interest expense | 24 | 122 | 66 | 177 |
| EBITDA | $9,938 | $13,287 | $37,935 | $62,420 |
| EBITDA margin | 8.1% | 11.0% | 9.7% | 15.1% |
| Net income margin | 3.9% | 6.1% | 5.2% | 9.2% |
27
Financial Condition
Liquidity and Capital Resources
At the end of the third quarter of 2024, the Company’s cash and short-term investments totaled $96.0 million. Pre-LIFO working capital of $260.4 million, less the LIFO reserve of $68.3 million, resulted in working capital of $192.1 million and a current ratio of 4.5 to 1.
Operations
Cash provided by operating activities was $35.5 million for the nine months ended September 28, 2024, compared to $1.3 million for the comparable prior year period. The increase in cash provided in the nine months ended September 28, 2024 is primarily attributable to decreases in inventory and prepaid expenses and other assets in the nine months ended September 28, 2024, partially offset by the decrease in net income in the nine months ended September 28, 2024.
Third parties supply the Company with various raw materials for its firearms and castings, such as steel, fabricated steel components, walnut, birch, beech, maple and laminated lumber for rifle stocks, wax, ceramic material, metal alloys, various synthetic products and other component parts. A limited supply of these materials in the marketplace can result in increases to purchase prices and adversely affect production levels. If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.
Investing and Financing
Capital expenditures for the nine months ended September 28, 2024 totaled $17.2 million, an increase from $11.6 million in the comparable prior year period. In 2024, the Company expects capital expenditures related to new product introductions and upgrades to our manufacturing equipment and facilities to total approximately $20 million. Actual capital expenditures could vary significantly from the projected amount due to the timing of capital projects. The Company finances, and intends to continue to finance, all of these activities with funds provided by operations and current cash and cash equivalents.
Dividends of $10.0 million were paid during the nine months ended September 28, 2024. The Company has financed its dividends with cash provided by operations and current cash. The quarterly dividend varies every quarter because the Company pays a percentage of earnings rather than a fixed amount per share. The Company’s practice is to pay a dividend of approximately 40% of net income.
On October 25, 2024, the Company’s Board of Directors authorized a dividend of 11¢ per share to shareholders of record on November 13, 2024, payable on November 27, 2024. The payment of future dividends depends on many factors, including internal estimates of future performance, then-current cash and short-term investments, and the Company’s need for funds.
As of September 28, 2024, the Company had $61.5 million of United States Treasury instruments which mature within one year. The Company also invests available cash in a bank-managed money market fund that invests exclusively in United States Treasury instruments which mature within one year. At September 28, 2024, the Company’s investment in this money market fund totaled $27.0 million.
During the nine months ended September 28, 2024 the Company purchased 698,759 shares of its common stock for $29.3 million in the open market. The average price per share purchased was $41.99. These purchases were funded with cash on hand. As of September 28, 2024, $45.3 million remained authorized for future stock repurchases.
Based on its unencumbered assets, the Company believes it has the ability to raise cash through the issuance of short-term or long-term debt. The Company’s unsecured $40 million credit facility, which expires on January 7, 2028, was unused at September 28, 2024.
Other Operational Matters
In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to workplace safety, firearms serial number tracking and control, waste disposal, air emissions and water discharges into the environment. The Company believes that it is generally in compliance with applicable Bureau of Alcohol, Tobacco, Firearms & Explosives, environmental, and safety regulations and the outcome of any proceedings or orders will not have a material adverse effect on the financial position or results of operations of the Company. If these regulations become more stringent in the future and the Company is not able to comply with them, such noncompliance could have a material adverse impact on the Company.
The Company has 15 independent distributors that service the domestic commercial market. Additionally, the Company has 44 and 26 distributors servicing the export and law enforcement markets, respectively.
The Company self-insures a significant amount of its product liability, workers’ compensation, medical, and other insurance. It also carries significant deductible amounts on various insurance policies. In September 2024, the Company did not renew its product liability coverage with its incumbent carriers and established a wholly-owned captive insurance company for claims made on or after September 1, 2024.
The Company expects to realize its deferred tax assets through tax deductions against future taxable income.
Adjustments to Critical Accounting Policies
The Company has not made any adjustments to its critical accounting estimates and assumptions described in the Company’s 2023 Annual Report on Form 10-K filed on February 21, 2024, or the judgments affecting the application of those estimates and assumptions.
Forward-Looking Statements and Projections
The Company may, from time to time, make forward-looking statements and projections concerning future expectations. Such statements are based on current expectations and are subject to certain qualifying risks and uncertainties, such as market demand, sales levels of firearms, anticipated castings sales and earnings, the need for external financing for operations or capital expenditures, the results of pending litigation against the Company, the impact of future firearms control and environmental legislation, and accounting estimates, any one or more of which could cause actual results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publish revised forward-looking statements to reflect events or circumstances after the date such forward-looking statements are made or to reflect the occurrence of subsequent unanticipated events.
Market risk
As filed, 317 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The interest rate market risk implicit to the Company at any given time is typically low, as the Company does not have significant exposure to changing interest rates on invested cash. There has been no material change in the Company’s exposure to interest rate risks during the three months ended September 28, 2024.
Controls and procedures
As filed, 2,040 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (the “Disclosure Controls and Procedures”), as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 28, 2024.
Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of September 28, 2024, such Disclosure Controls and Procedures are effective to ensure that information required to be disclosed in the Company’s periodic reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer or persons performing similar functions, as appropriate, to allow timely decisions regarding disclosure.
The Company’s Chief Executive Officer and Chief Financial Officer have further concluded that, as of September 28, 2024, there have been no material changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 28, 2024 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
The effectiveness of any system of internal controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that the Disclosure Controls and Procedures will detect all errors or fraud. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the internal control system will be attained.
Risk factors
As filed, 256 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
During the three months ended September 28, 2024, there were no material changes in the Company’s risk factors from the information provided in Item 1A. Risk Factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-06-30 to 2024-09-28 | $122.3m | us-gaap:Revenues |
| Revenue | 9 months2024-01-01 to 2024-09-28 | $389.9m | us-gaap:Revenues |
| Cost of revenue | 3 months2024-06-30 to 2024-09-28 | $99.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-01-01 to 2024-09-28 | $308.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-06-30 to 2024-09-28 | $22.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-01-01 to 2024-09-28 | $81.2m | us-gaap:GrossProfit |
| Operating income | 3 months2024-06-30 to 2024-09-28 | $3.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-01-01 to 2024-09-28 | $20.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-06-30 to 2024-09-28 | $24.0k | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2024-01-01 to 2024-09-28 | $66.0k | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2024-06-30 to 2024-09-28 | $527.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-01-01 to 2024-09-28 | $4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-06-30 to 2024-09-28 | $4.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-01-01 to 2024-09-28 | $20.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-06-30 to 2024-09-28 | $0.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-01-01 to 2024-09-28 | $1.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-06-30 to 2024-09-28 | $0.28 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-01-01 to 2024-09-28 | $1.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-06-30 to 2024-09-28 | 17,137,065 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-01-01 to 2024-09-28 | 17,455,265 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-01-01 to 2024-09-28 | $35.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-01-01 to 2024-09-28 | $17.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2024-01-01 to 2024-09-28 | $10.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2024-01-01 to 2024-09-28 | $29.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-09-28 | $7.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-28 | $247.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-28 | $373.5m | us-gaap:Assets |
| Current liabilities | At period end2024-09-28 | $55.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-09-28 | $314.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001174947-24-001190. Last ingested by Listed: Nov 4, 2026, 17:04 ET. Listed shows no prices and gives no investment advice.